Publications:

Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.

Oncotarget

Wei, Lei L; Chintala, Sreenivasulu S; Ciamporcero, Eric E; Ramakrishnan, Swathi S; Elbanna, May M; Wang, Jianmin J; Hu, Qiang Q; Glenn, Sean T ST; Murakami, Mitsuko M; Liu, Lu L; Gomez, Eduardo Cortes EC; Sun, Yuchen Y; Conroy, Jacob J; Miles, Kiersten Marie KM; Malathi, Kullappan K; Ramaiah, Sudha S; Anbarasu, Anand A; Woloszynska-Read, Anna A; Johnson, Candace S CS; Conroy, Jeffrey J; Liu, Song S; Morrison, Carl D CD; Pili, Roberto R

Publication Date: 2016-11-22

Variant appearance in text: SIRPG: V213V

PubMed Link: 27823983

Variant Present in the following documents:

• oncotarget-07-76374-s002.xlsx, sheet 2

View BVdb publication page